<DOC>
	<DOCNO>NCT02040376</DOCNO>
	<brief_summary>A placebo control double blind crossover trial metformin 30 child treat radiation medulloblastoma - common malignant brain tumour . The investigator use test think learn brain image technique examine whether metformin enhance cognition promote brain repair follow radiation-induced brain injury .</brief_summary>
	<brief_title>Placebo Controlled Double Blind Crossover Trial Metformin Brain Repair Children With Cranial-Spinal Radiation Medulloblastoma</brief_title>
	<detailed_description />
	<mesh_term>Medulloblastoma</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Inclusion criterion : Survivors include : 1 . Have treat cranial cranialspinal radiation , 2 . Are 5 21 year age time consent , 3 . Either declare English native language least two year school English time baseline assessment . 4 . Have diagnose brain tumour require treatment cranial cranialspinal radiation least 2 year ago , receive active treatment 15 year may elapse treatment cranialspinal radiation time trial . Survivors shunt included trial , need identify prior study enrollment discus specific consideration image . 5 . Meet criteria adequate organ function requirement : 1 . Adequate renal function define : Creatinine clearance radioisotope glomerular filtration rate ( GFR ) &gt; 70ml/min/1.73 m2 serum creatinine base age/gender follow : Maximum Serum Creatinine Level ( mg/dL ) 5 &lt; 10 year : Male = 1 ; Female = 1 10 &lt; 13 year : Male = 1.2 ; Female = 1.2 13 &lt; 16 year : Male = 1.5 ; Female = 1.4 â‰¥ 16 year : Male = 1.7 ; Female = 1.4 2 . Adequate liver function define : Total bilirubin &lt; 1.5 x upper limit normal ( ULN ) age , , serum glutamate oxaloacetate transaminase ( SGOT ) ( AST ) serum glutamate pyruvate transaminase ( SGPT ) ( ALT ) &lt; 3 x upper limit normal ( ULN ) age . 6 . Females childbearing potential must negative pregnancy test result must agree use medically acceptable method contraception throughout entire study period 30 day last dose study drug . 7 . Informed consent obtain participant and/or legal guardian study team member authorize consent study . Exclusion criterion : Survivors exclude 1 . Are receive palliative care . 2 . Are unable participate neuroimaging without sedation primary outcome measure trial . 3 . Are unable swallow tablet . 4 . Are unstable and/or insulindependent ( Type 1 ) diabetic patient . 5 . Have acute chronic metabolic acidosis and/or lactic acidosis . 6 . Any female patient partner reach menarche male patient willing use effective method contraception . 7 . Patient pregnant lactating agree stop breastfeed receive trial treatment . 8 . Have history renal disease renal dysfunction e.g. , suggest elevated serum creatinine level ( see 5.a . Inclusion criterion ) abnormal creatinine clearance . 9 . Have history congestive heart failure require pharmacologic treatment . 10 . Have know hypersensitivity metformin hydrochloride .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Paediatrics</keyword>
	<keyword>Medulloblastoma</keyword>
	<keyword>Metformin</keyword>
</DOC>